C5 and Sepsis: During sepsis, C5aRa treatment blocked chemotactic responses of neutrophils to C5a, and prevented C5a/C5aR-induced paralysis of innate immunity, which led to improved survival in a 9-days survival study (Huber-Lang et al., 2002a).